[Cost-effective drug utilization--what can the national drug agency do?]

Investigation of cardiovascular characteristics in a patient with hereditary hemorrhagic telangiectasia, a case report.

Physiological reports·2026

15O-water PET for evaluation of cardiopulmonary perfusion in complex cyanotic heart disease.

European journal of hybrid imaging·2021

SuperCam Calibration Targets: Design and Development.

Space science reviews·2020

MicroRNAs in metabolism.

Acta physiologica (Oxford, England)·2016

Analytical and numerical modelling of Newtonian and non-Newtonian liquid in a rotational cross-flow MBR.

Water science and technology : a journal of the International Association on Water Pollution Research·2012

Increased incidence of Mycoplasma pneumoniae infection in Norway 2011.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2012

Adnexal torsion due to teratoma in a young adolescent.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026

Acute dizziness - resource use and diagnosis with targeted clinical examination.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026

Data quality in the Norwegian National Quality Registry for Pain Management.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026

Containing outbreaks at their source: an illustrative example of partial economic returns to US global health security funding.

Journal of global health·2026

Pharmaceutical Expenditure Governance in the UK and Italy.

European journal of health law·2026

Ketogenic diet therapy for epilepsy in Australia: insights from the Pharmaceutical Benefits Scheme.

Internal medicine journal·2026

Assessment of IPAY 2027 Medicare drug price negotiation maximum fair prices with prices in most-favored nation reference countries.

Journal of managed care & specialty pharmacy·2026

First Year Of ACO Realizing Equity, Access, And Community Health Program Yields Good Quality, Savings Results.

Health affairs (Project Hope)·2026

Spending Impact of the First 10 Drugs Selected for Medicare Drug Price Negotiation in the United States.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Related Experiment Videos

[Cost-effective drug utilization--what can the national drug agency do?]

Related Concept Videos

Investigation of cardiovascular characteristics in a patient with hereditary hemorrhagic telangiectasia, a case report.

15O-water PET for evaluation of cardiopulmonary perfusion in complex cyanotic heart disease.

SuperCam Calibration Targets: Design and Development.

MicroRNAs in metabolism.

Analytical and numerical modelling of Newtonian and non-Newtonian liquid in a rotational cross-flow MBR.

Increased incidence of Mycoplasma pneumoniae infection in Norway 2011.

Adnexal torsion due to teratoma in a young adolescent.

Acute dizziness - resource use and diagnosis with targeted clinical examination.

Data quality in the Norwegian National Quality Registry for Pain Management.

Containing outbreaks at their source: an illustrative example of partial economic returns to US global health security funding.

Pharmaceutical Expenditure Governance in the UK and Italy.

Ketogenic diet therapy for epilepsy in Australia: insights from the Pharmaceutical Benefits Scheme.

Assessment of IPAY 2027 Medicare drug price negotiation maximum fair prices with prices in most-favored nation reference countries.

First Year Of ACO Realizing Equity, Access, And Community Health Program Yields Good Quality, Savings Results.

Spending Impact of the First 10 Drugs Selected for Medicare Drug Price Negotiation in the United States.

Related Experiment Videos

[Cost-effective drug utilization--what can the national drug agency do?]

Related Concept Videos

Related Articles